nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—Application site reaction—Niacin—atherosclerosis	0.0372	0.0829	CcSEcCtD
Fluocinonide—Dermatitis contact—Niacin—atherosclerosis	0.0172	0.0384	CcSEcCtD
Fluocinonide—Betamethasone—PLA2G1B—atherosclerosis	0.017	0.454	CrCbGaD
Fluocinonide—Skin exfoliation—Niacin—atherosclerosis	0.0167	0.0371	CcSEcCtD
Fluocinonide—Swelling—Simvastatin—atherosclerosis	0.0156	0.0348	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—EDNRA—atherosclerosis	0.014	0.0272	CbGpPWpGaD
Fluocinonide—Nasopharyngitis—Ezetimibe—atherosclerosis	0.0129	0.0288	CcSEcCtD
Fluocinonide—Dry skin—Niacin—atherosclerosis	0.0116	0.0258	CcSEcCtD
Fluocinonide—Dry skin—Pravastatin—atherosclerosis	0.0114	0.0255	CcSEcCtD
Fluocinonide—Nasopharyngitis—Pravastatin—atherosclerosis	0.0112	0.0248	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.0104	0.0202	CbGpPWpGaD
Fluocinonide—Dexamethasone—PLA2G1B—atherosclerosis	0.00988	0.264	CrCbGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00941	0.0183	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—NFKB1—atherosclerosis	0.00905	0.0176	CbGpPWpGaD
Fluocinonide—Immune system disorder—Ezetimibe—atherosclerosis	0.00904	0.0201	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—HRH1—atherosclerosis	0.00888	0.0173	CbGpPWpGaD
Fluocinonide—Erythema—Ezetimibe—atherosclerosis	0.00871	0.0194	CcSEcCtD
Fluocinonide—Infection—Rosuvastatin—atherosclerosis	0.0085	0.0189	CcSEcCtD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—AKT1—atherosclerosis	0.00849	0.0165	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00839	0.0187	CcSEcCtD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.00837	0.0163	CbGpPWpGaD
Fluocinonide—Erythema—Simvastatin—atherosclerosis	0.00831	0.0185	CcSEcCtD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.00794	0.0155	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.0078	0.0152	CbGpPWpGaD
Fluocinonide—Erythema—Niacin—atherosclerosis	0.00763	0.017	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00737	0.0164	CcSEcCtD
Fluocinonide—Pain—Rosuvastatin—atherosclerosis	0.00732	0.0163	CcSEcCtD
Fluocinonide—Infection—Lovastatin—atherosclerosis	0.0072	0.016	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.00713	0.0139	CbGpPWpGaD
Fluocinonide—Infection—Ezetimibe—atherosclerosis	0.00707	0.0157	CcSEcCtD
Fluocinonide—Nervous system disorder—Ezetimibe—atherosclerosis	0.00697	0.0155	CcSEcCtD
Fluocinonide—Skin disorder—Ezetimibe—atherosclerosis	0.00691	0.0154	CcSEcCtD
Fluocinonide—Infection—Simvastatin—atherosclerosis	0.00674	0.015	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.00656	0.0128	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00645	0.0144	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.00645	0.0126	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL4—atherosclerosis	0.00642	0.0125	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—RETN—atherosclerosis	0.0064	0.0125	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0063	0.014	CcSEcCtD
Fluocinonide—Pain—Lovastatin—atherosclerosis	0.0062	0.0138	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.0061	0.0119	CbGpPWpGaD
Fluocinonide—Infection—Pravastatin—atherosclerosis	0.00609	0.0136	CcSEcCtD
Fluocinonide—Pain—Ezetimibe—atherosclerosis	0.00608	0.0135	CcSEcCtD
Fluocinonide—Pruritus—Rosuvastatin—atherosclerosis	0.00605	0.0135	CcSEcCtD
Fluocinonide—Skin disorder—Niacin—atherosclerosis	0.00605	0.0135	CcSEcCtD
Fluocinonide—Pain—Simvastatin—atherosclerosis	0.0058	0.0129	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—F7—atherosclerosis	0.00578	0.0113	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.00574	0.0112	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—UTS2—atherosclerosis	0.00572	0.0111	CbGpPWpGaD
Fluocinonide—Dizziness—Rosuvastatin—atherosclerosis	0.00566	0.0126	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.00562	0.0109	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CX3CR1—atherosclerosis	0.00548	0.0107	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CASR—atherosclerosis	0.00548	0.0107	CbGpPWpGaD
Fluocinonide—Rash—Rosuvastatin—atherosclerosis	0.00539	0.012	CcSEcCtD
Fluocinonide—Dermatitis—Rosuvastatin—atherosclerosis	0.00539	0.012	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CX3CL1—atherosclerosis	0.00538	0.0105	CbGpPWpGaD
Fluocinonide—Headache—Rosuvastatin—atherosclerosis	0.00536	0.0119	CcSEcCtD
Fluocinonide—Hypersensitivity—Lovastatin—atherosclerosis	0.00534	0.0119	CcSEcCtD
Fluocinonide—Pain—Niacin—atherosclerosis	0.00533	0.0119	CcSEcCtD
Fluocinonide—Pain—Pravastatin—atherosclerosis	0.00524	0.0117	CcSEcCtD
Fluocinonide—Hypersensitivity—Ezetimibe—atherosclerosis	0.00524	0.0117	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.00518	0.0101	CbGpPWpGaD
Fluocinonide—Pruritus—Lovastatin—atherosclerosis	0.00513	0.0114	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.00512	0.00997	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CNR2—atherosclerosis	0.0051	0.00993	CbGpPWpGaD
Fluocinonide—Pruritus—Ezetimibe—atherosclerosis	0.00503	0.0112	CcSEcCtD
Fluocinonide—Hypersensitivity—Simvastatin—atherosclerosis	0.005	0.0111	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.00494	0.00962	CbGpPWpGaD
Fluocinonide—Pruritus—Simvastatin—atherosclerosis	0.0048	0.0107	CcSEcCtD
Fluocinonide—Dizziness—Lovastatin—atherosclerosis	0.00479	0.0107	CcSEcCtD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—AKT1—atherosclerosis	0.00471	0.00918	CbGpPWpGaD
Fluocinonide—Dizziness—Ezetimibe—atherosclerosis	0.0047	0.0105	CcSEcCtD
Fluocinonide—Hypersensitivity—Niacin—atherosclerosis	0.00459	0.0102	CcSEcCtD
Fluocinonide—Rash—Lovastatin—atherosclerosis	0.00457	0.0102	CcSEcCtD
Fluocinonide—Dermatitis—Lovastatin—atherosclerosis	0.00457	0.0102	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—HRH1—atherosclerosis	0.00456	0.00887	CbGpPWpGaD
Fluocinonide—Headache—Lovastatin—atherosclerosis	0.00454	0.0101	CcSEcCtD
Fluocinonide—Hypersensitivity—Pravastatin—atherosclerosis	0.00452	0.0101	CcSEcCtD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.00449	0.00874	CbGpPWpGaD
Fluocinonide—Dizziness—Simvastatin—atherosclerosis	0.00448	0.00998	CcSEcCtD
Fluocinonide—Rash—Ezetimibe—atherosclerosis	0.00448	0.00998	CcSEcCtD
Fluocinonide—Dermatitis—Ezetimibe—atherosclerosis	0.00448	0.00997	CcSEcCtD
Fluocinonide—Headache—Ezetimibe—atherosclerosis	0.00446	0.00992	CcSEcCtD
Fluocinonide—Dexamethasone—NOS2—atherosclerosis	0.00441	0.118	CrCbGaD
Fluocinonide—Pruritus—Niacin—atherosclerosis	0.00441	0.00981	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.00439	0.00855	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL3—atherosclerosis	0.00438	0.00854	CbGpPWpGaD
Fluocinonide—Pruritus—Pravastatin—atherosclerosis	0.00434	0.00966	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.00433	0.00843	CbGpPWpGaD
Fluocinonide—Rash—Simvastatin—atherosclerosis	0.00428	0.00952	CcSEcCtD
Fluocinonide—Dermatitis—Simvastatin—atherosclerosis	0.00427	0.00951	CcSEcCtD
Fluocinonide—Headache—Simvastatin—atherosclerosis	0.00425	0.00946	CcSEcCtD
Fluocinonide—Dizziness—Niacin—atherosclerosis	0.00412	0.00917	CcSEcCtD
Fluocinonide—Dizziness—Pravastatin—atherosclerosis	0.00405	0.00902	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.00405	0.00788	CbGpPWpGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.00398	0.00775	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.00398	0.00775	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—EDNRA—atherosclerosis	0.00396	0.00772	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCR2—atherosclerosis	0.00396	0.00772	CbGpPWpGaD
Fluocinonide—Rash—Niacin—atherosclerosis	0.00393	0.00874	CcSEcCtD
Fluocinonide—Dermatitis—Niacin—atherosclerosis	0.00392	0.00873	CcSEcCtD
Fluocinonide—Headache—Niacin—atherosclerosis	0.0039	0.00868	CcSEcCtD
Fluocinonide—Rash—Pravastatin—atherosclerosis	0.00387	0.00861	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—GHRL—atherosclerosis	0.00386	0.00753	CbGpPWpGaD
Fluocinonide—Dermatitis—Pravastatin—atherosclerosis	0.00386	0.0086	CcSEcCtD
Fluocinonide—Headache—Pravastatin—atherosclerosis	0.00384	0.00855	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.00377	0.00735	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.00374	0.00729	CbGpPWpGaD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.0037	0.00722	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.00366	0.00714	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.00363	0.00707	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—AHR—atherosclerosis	0.00351	0.00683	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.00349	0.00681	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00347	0.00676	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—KNG1—atherosclerosis	0.00339	0.00661	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—AGTR1—atherosclerosis	0.00337	0.00657	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.00334	0.00651	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL4—atherosclerosis	0.00329	0.00642	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.00327	0.00636	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.00317	0.00617	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00314	0.00612	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.00314	0.00612	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.00311	0.00607	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.00311	0.00605	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.0031	0.00605	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.00306	0.00597	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.00298	0.00581	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—UTS2—atherosclerosis	0.00294	0.00572	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.0029	0.00565	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00287	0.00559	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—EDN1—atherosclerosis	0.00286	0.00557	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL5—atherosclerosis	0.00284	0.00552	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CX3CR1—atherosclerosis	0.00281	0.00548	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CASR—atherosclerosis	0.00281	0.00548	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.00276	0.00538	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CX3CL1—atherosclerosis	0.00276	0.00538	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.00269	0.00525	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HRH1—atherosclerosis	0.00269	0.00524	CbGpPWpGaD
Fluocinonide—Triamcinolone—PTGS2—atherosclerosis	0.00266	0.0711	CrCbGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.00265	0.00516	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.00264	0.00515	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CNR2—atherosclerosis	0.00262	0.0051	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.00261	0.00508	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.00251	0.00488	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.00245	0.00476	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.00244	0.00475	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.00243	0.00474	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.00241	0.00469	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—AGT—atherosclerosis	0.00237	0.00462	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.00233	0.00453	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.00231	0.00451	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL3—atherosclerosis	0.00225	0.00438	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.00224	0.00437	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—F2—atherosclerosis	0.00219	0.00427	CbGpPWpGaD
Fluocinonide—Betamethasone—PTGS2—atherosclerosis	0.00218	0.0582	CrCbGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.00217	0.00423	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.00215	0.00418	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00212	0.00413	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.00212	0.00412	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOA4—atherosclerosis	0.00211	0.00411	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.0021	0.00408	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.00208	0.00406	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EDNRA—atherosclerosis	0.00203	0.00396	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR2—atherosclerosis	0.00203	0.00396	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GHRL—atherosclerosis	0.00198	0.00386	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL2—atherosclerosis	0.00195	0.00381	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL4—atherosclerosis	0.00195	0.00379	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.00187	0.00364	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LPL—atherosclerosis	0.00186	0.00362	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.00183	0.00356	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOA2—atherosclerosis	0.00182	0.00354	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.00178	0.00348	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KNG1—atherosclerosis	0.00174	0.00339	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—UTS2—atherosclerosis	0.00173	0.00338	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AGTR1—atherosclerosis	0.00173	0.00337	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.0017	0.00331	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CX3CR1—atherosclerosis	0.00166	0.00324	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASR—atherosclerosis	0.00166	0.00324	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.00164	0.0032	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.00164	0.00319	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CX3CL1—atherosclerosis	0.00163	0.00318	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.00161	0.00314	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—AGT—atherosclerosis	0.00159	0.0031	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.00156	0.00304	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LEP—atherosclerosis	0.00156	0.00303	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR2—atherosclerosis	0.00155	0.00301	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL8—atherosclerosis	0.00154	0.00301	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MMP3—atherosclerosis	0.00154	0.003	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.00154	0.00299	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.0015	0.00292	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EDN1—atherosclerosis	0.00147	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL5—atherosclerosis	0.00146	0.00284	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PRKCG—atherosclerosis	0.00138	0.0027	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VWF—atherosclerosis	0.00138	0.00268	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOC3—atherosclerosis	0.00137	0.00267	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LDLR—atherosclerosis	0.00136	0.00265	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.00136	0.00264	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.00134	0.00261	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—INS—atherosclerosis	0.00133	0.00259	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL3—atherosclerosis	0.00133	0.00259	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.00132	0.00256	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.0013	0.00252	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.00129	0.00251	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.00128	0.00249	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NCF1—atherosclerosis	0.00127	0.00248	CbGpPWpGaD
Fluocinonide—Dexamethasone—PTGS2—atherosclerosis	0.00127	0.0339	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.00127	0.00247	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.00122	0.00238	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AGT—atherosclerosis	0.00122	0.00237	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDNRA—atherosclerosis	0.0012	0.00234	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR2—atherosclerosis	0.0012	0.00234	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CYBA—atherosclerosis	0.0012	0.00233	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PARP1—atherosclerosis	0.00117	0.00228	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GHRL—atherosclerosis	0.00117	0.00228	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLAT—atherosclerosis	0.00117	0.00228	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.00115	0.00224	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—F2—atherosclerosis	0.00112	0.00219	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CG—atherosclerosis	0.00108	0.0021	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KNG1—atherosclerosis	0.00103	0.002	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AGTR1—atherosclerosis	0.00102	0.00199	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL2—atherosclerosis	0.001	0.00195	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLG—atherosclerosis	0.000996	0.00194	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000954	0.00186	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000945	0.00184	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SOCS3—atherosclerosis	0.000943	0.00184	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP3—atherosclerosis	0.000911	0.00177	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF2—atherosclerosis	0.000907	0.00177	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.000895	0.00174	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000895	0.00174	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOB—atherosclerosis	0.00088	0.00172	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDN1—atherosclerosis	0.000866	0.00169	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL5—atherosclerosis	0.00086	0.00167	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000858	0.00167	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LPL—atherosclerosis	0.000841	0.00164	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000841	0.00164	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000832	0.00162	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRKCG—atherosclerosis	0.000817	0.00159	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000801	0.00156	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPP1—atherosclerosis	0.000796	0.00155	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL8—atherosclerosis	0.000793	0.00154	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000783	0.00153	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.000775	0.00151	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.000772	0.0015	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFB—atherosclerosis	0.000737	0.00144	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000727	0.00142	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—atherosclerosis	0.00072	0.0014	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AGT—atherosclerosis	0.000719	0.0014	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—atherosclerosis	0.000705	0.00137	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LEP—atherosclerosis	0.000705	0.00137	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CAV1—atherosclerosis	0.000698	0.00136	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOA1—atherosclerosis	0.000697	0.00136	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ESR1—atherosclerosis	0.000673	0.00131	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—F2—atherosclerosis	0.000665	0.00129	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CG—atherosclerosis	0.000636	0.00124	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000623	0.00121	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAPK3—atherosclerosis	0.000609	0.00119	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—INS—atherosclerosis	0.000602	0.00117	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	0.000599	0.00117	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL2—atherosclerosis	0.000592	0.00115	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1—atherosclerosis	0.000582	0.00113	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—atherosclerosis	0.000581	0.00113	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SERPINE1—atherosclerosis	0.000553	0.00108	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	0.000543	0.00106	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOS3—atherosclerosis	0.000528	0.00103	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HSPA1B—atherosclerosis	0.000511	0.000995	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000502	0.000979	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	0.000495	0.000965	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL8—atherosclerosis	0.000468	0.000912	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PARP1—atherosclerosis	0.000455	0.000887	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000446	0.000869	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—atherosclerosis	0.000445	0.000867	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR2—atherosclerosis	0.000431	0.00084	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—atherosclerosis	0.000424	0.000825	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NFKB1—atherosclerosis	0.000419	0.000816	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK8—atherosclerosis	0.000412	0.000802	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—atherosclerosis	0.000411	0.0008	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—atherosclerosis	0.00038	0.000741	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—atherosclerosis	0.000377	0.000734	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK3—atherosclerosis	0.00036	0.000701	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFB1—atherosclerosis	0.000349	0.00068	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SIRT1—atherosclerosis	0.000347	0.000676	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARA—atherosclerosis	0.000289	0.000562	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—atherosclerosis	0.000263	0.000512	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR1—atherosclerosis	0.000261	0.000509	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—atherosclerosis	0.000243	0.000473	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—atherosclerosis	0.000238	0.000465	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SERPINE1—atherosclerosis	0.000215	0.000419	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MAPK3—atherosclerosis	0.00014	0.000272	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—atherosclerosis	9.43e-05	0.000184	CbGpPWpGaD
